Recent trends in pharmacotherapy for anxiety disorders

Japanese Journal of Neuropsychopharmacology

Volumn 24, Issue 3, 2004, Pages 133-136

  Tajima, Osamu ^a  

^a KYORIN UNIVERSITY   (Japan)

Author keywords

Amygdala; Anxiety disorders; Benzodiazepines; Pharmacotherapy; SSRIs

Indexed keywords

4 AMINOBUTYRIC ACID; BENZODIAZEPINE DERIVATIVE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AMYGDALOID NUCLEUS; ANXIETY DISORDER; BEHAVIOR THERAPY; CLINICAL PRACTICE; COGNITIVE THERAPY; DRUG CHOICE; DRUG DEPENDENCE; DRUG MECHANISM; FEAR; GABAERGIC TRANSMISSION; HUMAN; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTSYNAPTIC MEMBRANE; PREFRONTAL CORTEX; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; REVIEW; SOCIAL PHOBIA;

AMYGDALA; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; BENZODIAZEPINES; DRUG THERAPY, COMBINATION; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PANIC DISORDER; PHOBIC DISORDERS; SEROTONIN UPTAKE INHIBITORS;

EID: 3242784270     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Furmark, T., Tillfors, M., Marteinsdottir, I., Fischer, H., Pissiota, A., Langstrom, B. and Fredrikson, M. (2002) Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry, 59: 425-433.
2. Goodman, W. K., Price, L. H., Delgado, P. L., Palumbo, J., Krystal, J. H., Nagy, L. M., Rasmussen, S. A., Heninger, G. R. and Charney, D. S. (1990) Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry, 47: 577-585.
3. Liebowitz, M. R., Stein, M. B., Tancer, M., Carpenter, D., Oakes, R. and Pitts, C. D. (2002) Randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. J Clin Psychiatry, 63: 66-74.
4. Stahl, S. M. (2002a) Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder. J Clin Psychiatry, 63: 756-757.
5. Stahl, S. M. (2002b) Independent actions on fear circuits may lead to therapeutic synergy for anxiety when combining serotonergic and GABAergic agents. J Clin Psychiatry, 63: 854-855.
6. Stein, M. B., Liebowitz, M. R., Lydiard, R. B., Pitts, C. D., Bushnell, W. and Gergel, I. (1998) Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial. JAMA, 280: 708-713.
7. Stein, M. B., Fyer, A. J., Davidson, J. R., Pollack, M. H. and Wiita, B. (1999) Fluvoxamine treatment of social phobia (social anxiety disorder): A double-blind, placebo-controlled study. Am J Psychiatry, 156: 756-760.
8. Stein, M. B., Goldin, P. R., Sareen, J., Zorrilla, L. T. and Brown, G. G. (2002) Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry, 59: 1027-1034.
9. Uhlenhuth, E. H., Balter, M. B., Ban, T. A. and Yang, K. (1999) Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997. Eur Neuropsychopharmacol, 9 (Suppl): S393-S398.